Irene Arduino
Orbassano, 10043, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Broad-Spectrum Antiviral Activity of Pyridobenzothiazolone Analogues Against Respiratory Viruses.
Journal: Viruses
Published: April 23, 2025
Development of a virulent O'nyong'nyong challenge model to determine heterologous protection mediated by a hydrogen peroxide-inactivated chikungunya virus vaccine.
Journal: PLoS neglected tropical diseases
Published: November 01, 2024
The antipsychotic drug lurasidone inhibits coronaviruses by affecting multiple targets.
Journal: Frontiers in cellular and infection microbiology
Published: August 28, 2024
4-(3-Phenylsulfonylindol-2-yl)-1-(pyridin-2-yl)piperazinyl-methanones as Potent Inhibitors of both SARS-CoV-2 and HCoV-OC43 Viruses.
Journal: ACS infectious diseases
Published: August 03, 2024
Polyoxometalate exerts broad-spectrum activity against human respiratory viruses hampering viral entry.
Journal: Antiviral research
Published: February 07, 2024
Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis.
Journal: Frontiers in immunology
Published: April 14, 2023
The Peptide A-3302-B Isolated from a Marine Bacterium Micromonospora sp. Inhibits HSV-2 Infection by Preventing the Viral Egress from Host Cells.
Journal: International journal of molecular sciences
Published: December 17, 2021
Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors.
Journal: Antiviral research
Published: November 17, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026